Prostatic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
|
17013881 |
2007 |
Malignant neoplasm of prostate
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
|
17013881 |
2007 |
Breast Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
The functions of human D52 and D53 genes were then compared by stable expression in BALB/c 3T3 fibroblasts and transient gene knockdown in breast carcinoma cell lines.
|
18698023 |
2008 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
We validated significant overexpression of transcripts for HOXC10 (P=0.001), TPD52L1 (P=0.007), ZFP36L1 (P=0.011), PLINP1 (P=0.013), DCTN3 (P=0.025), DEK (P=0.031), and CSNK1D (P=0.04) in lymph node (+) breast carcinomas.
|
17855657 |
2007 |
Breast Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Co-expressed hD53 and 14-3-3 proteins were similarly demonstrated to co-localise within the cytoplasm of breast carcinoma cell lines.
|
12963375 |
2003 |
Breast Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Similarly, extensive two-hybrid screenings of a human breast carcinoma expression library identified hD53 and hD52 as potential interactors for both hD52 and hD53 baits.
|
9484778 |
1998 |
Breast Carcinoma
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
We report the identification of a mouse cDNA Tpd52l1 (tumor protein D52-like 1), which represents the first demonstrated orthologue of the human TPD52L1 (alias D53) gene, a member of the breast carcinoma-associated TPD52 (alias D52) gene family.
|
9730602 |
1998 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Cloning is reported of a cDNA homologue to the breast carcinoma-associated D52 cDNA, termed D53, and of a mouse D52 cDNA (HGMW-approved symbols TPD52L1 and TPD52).
|
8812487 |
1996 |
Non-Small Cell Lung Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In summary, TPD52L1-ROS1 is a novel ROS1 fusion variant in NSCLC identified by comprehensive genomic profiling and should be included in any ROS1 detecting assays that depend on identifying the corresponding fusion partners, such as reverse transcriptase-polymerase chain reaction (RT-PCR).
|
27237027 |
2016 |
Ulcerative Colitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Nine genes (ACSL1, BIRC3, CLC, CREM, ELTD1, FGG, S100A9, THBD, and TPD52L1) were progressively and significantly upregulated from controls to nondysplastic UC to UC with neoplasia.
|
23388545 |
2013 |
Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Nine genes (ACSL1, BIRC3, CLC, CREM, ELTD1, FGG, S100A9, THBD, and TPD52L1) were progressively and significantly upregulated from controls to nondysplastic UC to UC with neoplasia.
|
23388545 |
2013 |
Mammary Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
We observed coexpression of the human D52 and D53 genes in some breast tumors and derivative cell lines and found that maintenance of D52 and D53 transcript levels in estrogen receptor-positive MCF7 breast carcinoma cells depends upon estradiol.
|
8812487 |
1996 |